You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Alcohol consumption and breast cancer risk by estrogen receptor status: in a pooled analysis of 20 studies
|
|---|---|
| Published in |
International Journal of Epidemiology, August 2015
|
| DOI | 10.1093/ije/dyv156 |
| Pubmed ID | |
| Authors |
Seungyoun Jung, Molin Wang, Kristin Anderson, Laura Baglietto, Leif Bergkvist, Leslie Bernstein, Piet A van den Brandt, Louise Brinton, Julie E Buring, A Heather Eliassen, Roni Falk, Susan M Gapstur, Graham G Giles, Gary Goodman, Judith Hoffman-Bolton, Pamela L Horn-Ross, Manami Inoue, Laurence N Kolonel, Vittorio Krogh, Marie Lof, Paige Maas, Anthony B Miller, Marian L Neuhouser, Yikyung Park, Kim Robien, Thomas E Rohan, Stephanie Scarmo, Leo J Schouten, Sabina Sieri, Victoria L Stevens, Schoichiro Tsugane, Kala Visvanathan, Lynne R Wilkens, Alicja Wolk, Elisabete Weiderpass, Walter C Willett, Anne Zeleniuch-Jacquotte, Shumin M Zhang, Xuehong Zhang, Regina G Ziegler, Stephanie A Smith-Warner |
| Abstract |
Breast cancer aetiology may differ by estrogen receptor (ER) status. Associations of alcohol and folate intakes with risk of breast cancer defined by ER status were examined in pooled analyses of the primary data from 20 cohorts. During a maximum of 6-18 years of follow-up of 1 089 273 women, 21 624 ER+ and 5113 ER- breast cancers were identified. Study-specific multivariable relative risks (RRs) were calculated using Cox proportional hazards regression models and then combined using a random-effects model. Alcohol consumption was positively associated with risk of ER+ and ER- breast cancer. The pooled multivariable RRs (95% confidence intervals) comparing ≥ 30 g/d with 0 g/day of alcohol consumption were 1.35 (1.23-1.48) for ER+ and 1.28 (1.10-1.49) for ER- breast cancer (Ptrend ≤ 0.001; Pcommon-effects by ER status: 0.57). Associations were similar for alcohol intake from beer, wine and liquor. The associations with alcohol intake did not vary significantly by total (from foods and supplements) folate intake (Pinteraction ≥ 0.26). Dietary (from foods only) and total folate intakes were not associated with risk of overall, ER+ and ER- breast cancer; pooled multivariable RRs ranged from 0.98 to 1.02 comparing extreme quintiles. Following-up US studies through only the period before mandatory folic acid fortification did not change the results. The alcohol and folate associations did not vary by tumour subtypes defined by progesterone receptor status. Alcohol consumption was positively associated with risk of both ER+ and ER- breast cancer, even among women with high folate intake. Folate intake was not associated with breast cancer risk. |
X Demographics
The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 20% |
| Spain | 3 | 15% |
| United Kingdom | 2 | 10% |
| Australia | 1 | 5% |
| France | 1 | 5% |
| Japan | 1 | 5% |
| Unknown | 8 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 80% |
| Practitioners (doctors, other healthcare professionals) | 3 | 15% |
| Science communicators (journalists, bloggers, editors) | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 295 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Sweden | 1 | <1% |
| Pakistan | 1 | <1% |
| Unknown | 292 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 33 | 11% |
| Student > Bachelor | 30 | 10% |
| Student > Ph. D. Student | 26 | 9% |
| Researcher | 23 | 8% |
| Student > Postgraduate | 17 | 6% |
| Other | 46 | 16% |
| Unknown | 120 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 64 | 22% |
| Biochemistry, Genetics and Molecular Biology | 27 | 9% |
| Nursing and Health Professions | 19 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 5% |
| Agricultural and Biological Sciences | 12 | 4% |
| Other | 31 | 11% |
| Unknown | 128 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 February 2021.
All research outputs
#1,649,870
of 25,727,480 outputs
Outputs from International Journal of Epidemiology
#826
of 5,942 outputs
Outputs of similar age
#21,378
of 280,836 outputs
Outputs of similar age from International Journal of Epidemiology
#14
of 70 outputs
Altmetric has tracked 25,727,480 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,942 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.0. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 280,836 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.